New ICD-10-CM Codes in
205 codes were added to the 2022 ICD-10-CM code set, effective October 1, 2021.
Displaying codes 1-100 of 205:
-
A79.82 Anaplasmosis [A. phagocytophilum]
-
C56.3 Malignant neoplasm of bilateral ovaries
-
C79.63 Secondary malignant neoplasm of bilateral ovaries
-
C84.7A Anaplastic large cell lymphoma, ALK-negative, breast
-
D55.2 Anemia due to disorders of glycolytic enzymes
-
D55.21 Anemia due to pyruvate kinase deficiency
-
D55.29 Anemia due to other disorders of glycolytic enzymes
-
D75.83 Thrombocytosis
-
D75.838 Other thrombocytosis
-
D75.839 Thrombocytosis, unspecified
-
D89.44 Hereditary alpha tryptasemia
-
E75.244 Niemann-Pick disease type A/B
-
F32.A Depression, unspecified
-
F78 Other intellectual disabilities
-
F78.A Other genetic related intellectual disabilities
-
F78.A1 SYNGAP1-related intellectual disability
-
F78.A9 Other genetic related intellectual disability
-
G04.82 Acute flaccid myelitis
-
G44.86 Cervicogenic headache
-
G92 Toxic encephalopathy
-
G92.0 Immune effector cell-associated neurotoxicity syndrome
-
G92.00 Immune effector cell-associated neurotoxicity syndrome, grade unspecified
-
G92.01 Immune effector cell-associated neurotoxicity syndrome, grade 1
-
G92.02 Immune effector cell-associated neurotoxicity syndrome, grade 2
-
G92.03 Immune effector cell-associated neurotoxicity syndrome, grade 3
-
G92.04 Immune effector cell-associated neurotoxicity syndrome, grade 4
-
G92.05 Immune effector cell-associated neurotoxicity syndrome, grade 5
-
G92.8 Other toxic encephalopathy
-
G92.9 Unspecified toxic encephalopathy
-
I5A Non-ischemic myocardial injury (non-traumatic)
-
K22.8 Other specified diseases of esophagus
-
K22.81 Esophageal polyp
-
K22.82 Esophagogastric junction polyp
-
K22.89 Other specified disease of esophagus
-
K31.A Gastric intestinal metaplasia
-
K31.A0 Gastric intestinal metaplasia, unspecified
-
K31.A1 Gastric intestinal metaplasia without dysplasia
-
K31.A11 Gastric intestinal metaplasia without dysplasia, involving the antrum
-
K31.A12 Gastric intestinal metaplasia without dysplasia, involving the body (corpus)
-
K31.A13 Gastric intestinal metaplasia without dysplasia, involving the fundus
-
K31.A14 Gastric intestinal metaplasia without dysplasia, involving the cardia
-
K31.A15 Gastric intestinal metaplasia without dysplasia, involving multiple sites
-
K31.A19 Gastric intestinal metaplasia without dysplasia, unspecified site
-
K31.A2 Gastric intestinal metaplasia with dysplasia
-
K31.A21 Gastric intestinal metaplasia with low grade dysplasia
-
K31.A22 Gastric intestinal metaplasia with high grade dysplasia
-
K31.A29 Gastric intestinal metaplasia with dysplasia, unspecified
-
L24.A Irritant contact dermatitis due to friction or contact with body fluids
-
L24.A0 Irritant contact dermatitis due to friction or contact with body fluids, unspecified
-
L24.A1 Irritant contact dermatitis due to saliva
-
L24.A2 Irritant contact dermatitis due to fecal, urinary or dual incontinence
-
L24.A9 Irritant contact dermatitis due friction or contact with other specified body fluids
-
L24.B Irritant contact dermatitis related to stoma or fistula
-
L24.B0 Irritant contact dermatitis related to unspecified stoma or fistula
-
L24.B1 Irritant contact dermatitis related to digestive stoma or fistula
-
L24.B2 Irritant contact dermatitis related to respiratory stoma or fistula
-
L24.B3 Irritant contact dermatitis related to fecal or urinary stoma or fistula
-
M31.1 Thrombotic microangiopathy
-
M31.10 Thrombotic microangiopathy, unspecified
-
M31.11 Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA]
-
M31.19 Other thrombotic microangiopathy
-
M35.05 Sjogren syndrome with inflammatory arthritis
-
M35.06 Sjogren syndrome with peripheral nervous system involvement
-
M35.07 Sjogren syndrome with central nervous system involvement
-
M35.08 Sjogren syndrome with gastrointestinal involvement
-
M35.0A Sjogren syndrome with glomerular disease
-
M35.0B Sjogren syndrome with vasculitis
-
M35.0C Sjogren syndrome with dental involvement
-
M45.A Non-radiographic axial spondyloarthritis
-
M45.A0 Non-radiographic axial spondyloarthritis of unspecified sites in spine
-
M45.A1 Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region
-
M45.A2 Non-radiographic axial spondyloarthritis of cervical region
-
M45.A3 Non-radiographic axial spondyloarthritis of cervicothoracic region
-
M45.A4 Non-radiographic axial spondyloarthritis of thoracic region
-
M45.A5 Non-radiographic axial spondyloarthritis of thoracolumbar region
-
M45.A6 Non-radiographic axial spondyloarthritis of lumbar region
-
M45.A7 Non-radiographic axial spondyloarthritis of lumbosacral region
-
M45.A8 Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region
-
M45.AB Non-radiographic axial spondyloarthritis of multiple sites in spine
-
M54.5 Low back pain
-
M54.50 Low back pain, unspecified
-
M54.51 Vertebrogenic low back pain
-
M54.59 Other low back pain
-
P00.82 Newborn affected by (positive) maternal group B streptococcus (GBS) colonization
-
P09 Abnormal findings on neonatal screening
-
P09.1 Abnormal findings on neonatal screening for inborn errors of metabolism
-
P09.2 Abnormal findings on neonatal screening for congenital endocrine disease
-
P09.3 Abnormal findings on neonatal screening for congenital hematologic disorders
-
P09.4 Abnormal findings on neonatal screening for cystic fibrosis
-
P09.5 Abnormal findings on neonatal screening for critical congenital heart disease
-
P09.6 Abnormal findings on neonatal screening for neonatal hearing loss
-
P09.8 Other abnormal findings on neonatal screening
-
P09.9 Abnormal findings on neonatal screening, unspecified
-
R05 Cough
-
R05.1 Acute cough
-
R05.2 Subacute cough
-
R05.3 Chronic cough
-
R05.4 Cough syncope
-
R05.8 Other specified cough
-
R05.9 Cough, unspecified
